Conference materials
2023
Wennekes, M., Almási, T., Eilers, R., Mezei, F., Petykó, Z., Timen, A., Vokó, Z. Characteristics of effective educational interventions targeting healthcare workers to improve advising about vaccinations for older adults: a systematic review, Population Medicine, Supplement 5, page 562, A1990. 2-6 May 2023
2022
Elezbawy, B., Fasseeh, A.N., Eldessouki, R., Kirollos, M.G., Eldebeiky, M., Sedrak, A.S., Amer, H., Elnashar, S.A.A., Morsy, A., Amin, A.A., Saad, A.S., Abaza, S., Kalo, Z. POSA259 A Multi-Criteria Decision Analysis (MCDA) Tool for Purchasing Off-Patent Oncology Drugs in Egypt, Value in Health, Volume 25, Issue 1, Page S170, 1st March 2022
Fasseeh, A.N., Elezbawy, B., Ibrahim, N., Kirollos, M.G., Eldebeiky, M., Sedrak, A.S., Eldessouki, R., Boles, M., Marwa, E., Abaza, S., Kalo, Z. POSB253 Development of a Multi Criteria Decision Analysis (MCDA) Tool for Medical Devices National Procurement in Egypt, Value in Health, Volume 25, Issue 1, Page S176, 1st January 2022
Fasseeh, A.N., Elezbawy, B., Tannira, M., Dalle, H., Aderian, S., Abaza, S., Kalo, Z. ECONOMIC BURDEN OF DEPRESSION WITH CONCURRENT ANXIETY IN A GENERAL POPULATION OF US ADULTS BASED ON NATIONAL HEALTH AND WELLNESS SURVEY (NHWS), VALUE IN HEALTH, Volume 25, Issue 1, Pages S127-S127, 1st January 2022
Fasseeh, A.N., Elezbawy, B., Korra, N., Sedrak, A. S., Kirollos, M. G., Eldessouki, R., Eldebeiky, M., George, M., Seyam, A., Abourawash, A. , Kalo, Z. POSB205 Framework for Implementing Cost-Effectiveness Thresholds in Egypt, Value in Health, Volume 25, Issue 1, Page S145, 1st January 2022
Fasseeh, A.N., Elezbawy, B., Fouly, E., Tannira, M., Dalle, H., Aderian, S., Abaza, S., Kalo, Z. POSA169 Economic and Humanistic Burden of Atopic Dermatitis in the Middle East Africa Region in Adults & Adolescents, Value in Health, Volume 25, Issue 1, Page S120, 1st January 2022
Fasseeh, A.N., Elezbawy, B., Tannira, M., Dalle, H., Aderian, S., Abaza, S., Kalo, Z. POSB168 The Burden of Atopic Dermatitis in Adults and Adolescents: A Systematic Literature Review, Value in Health, Volume 25, Issue 1, Page S127, 1st January 2022
Kollányi, Zs., Gervai, N., Csanádi, M., Zemplényi, A., Szécsényi-Nagy, B. Adherence towards public health interventions (PHI) in COVID-19 – lessons from system dynamics. 15th European Public Health Conference, poster, Berlin, Germany, 9 – 12 November 2022
Kovacs, G., Abonyi-Tóth, Z., Fadgyas-Freyler, P., Kalo, Z. POSB69 Incremental Costs Analysis of Prematurity in Hungary, Value in Health, Volume 25, Issue 1, Pages S73-S74, 1st January 2022
Tadić, I., van Bovenm, J., Tsiligianni, I., Potočnjak, I., Mihajlović, J., Dima, A. L., Makovec, U. N., Ágh, T., Kardas, P., Ghiciuc, C. M., Petrova, G., Bitterman, N., Kamberi, F., Culig, J., Wettermark, B., Marinković, V. Advancement of practice and use of medication adherence technologies, Arhiv Za Faramaciju, Volume 72, Pages S202–S203, 12th October 2022
2021
Kovács, S., Bendes, R., Kaló, Z., Kolasa, K., Hren, R., Tesar, T., Reckers-Droog, V., Brouwer, W., Federici, C., Torbica, A. PNS77 Transferring Health Technology Assessments from EARLY Adopter to Late Adopter Countries: Recommendations for the Implementation of CED Schemes in Central and Eastern European Countries, Value in Health, Volume 24, Supplement 1, Page S187, 1st June 2021
Choon-Quinones, M., Hose, D., Kalo, Z., Jakab, I., Yucel, E., Zelei, T., Harousseau, J. L., Durie, B., Keown, P., Barnett, M. PCN142 Patient and Caregiver Preferences in Treatment Decision Making in Multiple Myeloma—Results of a Targeted Literature Review, Value in Health, Volume 24, Supplement 1, Page S45, 1st June 2021
Németh, B., Choon-Quinones, M., Tóth, M., Jia, X.Y., Zelei, T., Kaló, Z., Harousseau, J.L., Hose, D., Durie, B., Keown, P., Barnett, M. Systematic Literature Review of Health Economic Models Developed for Myeloma. Virtual ISPOR 2021, poster, 17-20 May 2021
2020
Inotai, A., Senkus, E, Maris, R.T., Kovács, S., Kaló, Z., Tamas, A. PCN39 Impact of Medication Non-Adherence on Hard Clinical Endpoints in Patients with Breast Cancer: Results of a Systematic Literature Review, Value in Health, Volume 23, Supplement 2 Page S428, 1st December 2020
Fasseeh, A.N., Elezbawy, B. Korra, N., Khalil, A., Dawood, H., Askar, S., Abaza, S. Kalo, Z. PNS128 Implementation of Health Technology Assessment in Egypt: Comparison between the Current and Preferred Status, Value in Health, Volume 23, Supplement 2, Page S662, 1st December 2020
Petykó, Z., Kaló, Z., Espin, J., Fricke, F.U., Hawkins, N. S., Maniadakis, N., Podrazilova, K., Tesar, T., Inotai, A. PNS108 Proposal for a Core Evaluation Framework of Value Added Medicines, Value in Health, Volume 23, Supplement 2, Pages S659-S660, 1st December 2020
Fasseeh, A.N., Adel, R., Elezbawy, B., Abouelmaged, E., Abaza, S., Kaló, Z. PNS55 Managed Entry Agreements in Egypt: Current Practices and Future Preferences, Value in Health, Volume 23, Supplement 2, Pages S652-S653,1st December 2020
Kovács, S., Finn, P., Lukacs, C., Kacena, K., Vokó, Z., Zelei, T. Systematic Literature Review on the Epidemiology of Glycogen Storage Disease Type 1A (GSD 1A), poster, Italy, Milan, 16-19 November 2020
Németh, B., Jakab, I., Kaló, Z. Patient Representation in Health Policy Decisions - Learnings from an ISPOR Hungary Chapter Project. Virtual ISPOR Europe 2020, poster, Italy, Milan,16-19 November, 2020
Ágh, T., Németh, B., Erler, N., Csanádi, M., Bacon, T. Estimating the Number of Multiple Myeloma Patients in Europe who have been Exposed to Proteasome Inhibitors, Immunomodulatory Drugs and ANTI-CD38 Monoclonal Antibody Therapy. Virtual ISPOR Europe 2020, poster, 16-19 November 2020
Incze, A., Espin, J., Kalo, Z., Kiss, E., Garrison, L. P. PNS95 International Reference Pricing: Acceptance And Avoidance Behaviors Affecting Patient Access And Innovation In U.S. And Beyond, Value in Health, Volume 23, Supplement 1, Page S301, 1st May 2020
Kalo, Z., Valyi-Nagy, I., Szekely, A., Szikora, B., Bendes, R., Varga, G., Szilberhorn, L., Nagy, B., Mikala, G., Kacskovics, I. PPM6 early phase economic evaluation of new generation sequence diagnostics in multiple myeloma, Value in Health, Volume 23, Supplement 1, Pages S326-S327, 1st May 2020
Choon-Quinones, M., Zelei, T., Barnett, M., Keown, P., Durie, B., Kalo, Z., Almasi, T., Harousseau, J.-L., Hose, D., Sanguinetti, C.Exploring the True Cost of Multiple Myeloma, AMERICAN JOURNAL OF HEMATOLOGY, Volume 95, Pages S8-S9, 2020
García-Sáez, G., Goettsch, W., De Vries, F., Driessen, A., Németh, B., Petrova, G., Sirtola, P., Roning, J., Zemplényi, A.T., Hernando, M.E. Next Generation Health Technology Assessment to support patient-centered, societally oriented, real-time decision-making in Diabetes. 13th International Conference on Advanced Technologies and Treatments for Diabetes, Madrid, Spain, 19-22 February 2020
2019
Almomani, E., Alabbadi, I., Fasseeh, A.N., Al-Sharu, E., Kalo, Z. PNS259 NATIONAL HTA IMPLEMENTATION IN MIDDLE-INCOME COUNTRIES, THE CASE OF JORDAN,
Value in Health, Volume 22, Supplement 3, Page S806, November 2019
Abouelmaged, E., Fasseeh, A.N., Elezbawy, B., Khalil, A., Dawood, H., Askar, S., Abaza, S., Kalo, Z. PNS121 PRIVATE HEALTH INSURANCE COLLABORATION WITH PHARMACEUTICAL COMPANIES IN EGYPT, Value in Health, Volume 22, Supplement 3, Page S782, November 2019
Szilberhorn, L., Kalo, Z., Agh, T. PIN64 COST OF HEPATITIS C VIRUS ERADICATION: ECONOMIC MODEL CONCEPT, Value in Health, Volume 22, Supplement 3,
Page S650, November 2019
Kovacs, G., Kalo, Z. PIH14 INCREMENTAL COSTS OF PREMATURITY AND LOW BIRTHWEIGHT, Value in Health, Volume 22, Supplement 3, Page S630, November 2019
Zemplényi, A., Pitter, J. G., Bendes, R., Csanádi, M., Csikós, Á., Kaló, Z. PCN125 IMPACT OF PALLIATIVE CARE CONSULT SERVICES ON THE COST OF CARE IN HUNGARY, Value in Health, Volume 22, Supplement 3, Page S460, November 2019
Petykó, Z., Inotai, A., Kaló, Z. PDG10 IMPROVING THE BUSINESS MODEL OF VALUE ADDED MEDICINES: NEW VALUE ASSESSMENT FRAMEWORK IS NEEDED,
Value in Health, Volume 22, Supplement 3, Page S598, November 2019
Gyimesi, N., Kalo, Z., Inotai, A. PNS290 EVIDENCE-BASED VALUE FRAMEWORK FOR THE EVALUATION OF CLINICAL PHARMACY SERVICES, Value in Health,
Volume 22, Supplement 3, Page S218, November 2019,
Voko, Z., Molnar, A., Valay, V., Moizs, M., Kerpel-Fronius, A., Bajzik, G., Horvath, I., Nagy, B. Cost-effectiveness analysis of low-dose computed tomography screening for lung cancer in Hungary. 12th European Public Health Conference. Marseilles 20-23 November 2019
Voko, Z., Bitter, I., Mersich, B., Rethelyi, J., Molnar, A., Pitter, J., Gotze, A., Ruzsa, V., Koczian, K., Fonticoli, L., Lelli, F., Nemeth, B. BAYESIAN ESTIMATION OF THE TRANSITION PROBABILITY MATRIX IN MARKOV MODELLING WITH INFORMATIVE PRIOR AN EXAMPLE FROM THE ANALYSIS OF THE TREATMENT OF PATIENTS WITH PREDOMINANT NEGATIVE SYMPTOMS OF SCHIZOPHRENIA WITH CARIPRAZINE - ISPOR 22st Annual European Congress, poster, Copenhagen, Denmark, 2-6 November, 2019
Agh, T., Voko, Z., Gros, B., Bacon, T., Csanadi, M. ESTIMATING THE NUMBER OF PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE ACROSS EUROPE - ISPOR 22nd Annual European Congress, poster, Copenhagen, Denmark, 2-6 November 2019
Csanadi, M., Farkas-Raduly, Sz., Gros, B., Bacon, T., Tapprich, C., Trudeau, J., Agh, T. PATIENT-REPORTED SYMPTOM BURDEN OF CHRONIC GRAFT VERSUS HOST DISEASE: A SYSTEMATIC LITERATURE REVIEW - ISPOR 22st Annual European Congress, poster, Copenhagen, Denmark, 2-6 November 2019
Petyko, Zs., Inotai, A. , Kalo, Z. IMPROVING THE BUSINESS MODEL OF VALUE ADDED MEDICINES: NEW VALUE ASSESSMENT FRAMEWORK IS NEEDED - ISPOR 22nd Annual European Congress, poster, Copenhagen, Denmark, 2-6 November 2019
Szilberhorn, L., Kalo, Z., Agh, T. COST OF HEPATITIS C VIRUS ERADICATION: ECONOMIC MODEL CONCEPT - ISPOR 22st Annual European Congress, poster, Copenhagen, Denmark, 2-6 November 2019
Zemplenyi, A., Pitter, J. G., Bendes, R., Csanadi, M., Csikos, A., Kalo, Z. IMPACT OF PALLIATIVE CARE CONSULT SERVICES ON THE COST OF CARE IN HUNGARY -ISPOR 22st Annual European Congress, poster, Copenhagen, Denmark, 2-6 November 2019
Zemplenyi, A., Peultier, A., Kovacs, S., Gazso, T., Szapary, L. ACCESS TO INTRAVENOUS TISSUE LIKE PLASMINOGEN ACTIVATOR (IV TPA) THERAPY AND MECHANICAL THROMBECTOMY (MT) FOR PATIENTS WITH ACUTE ISCHEMIC STROKE IN HUNGARY - ISPOR 22nd Annual European Congress, poster, Copenhagen, Denmark, 2-6 November 2019
Kovacs, G., Kalo, Z. INCREMENTAL COSTS OF PREMATURITY AND LOW BIRTHWEIGHT - ISPOR 22nd Annual European Congress, poster, Copenhagen, Denmark, 2-6 November 2019
Kalo, Z., Igarashi, A., Jakab, I., Gilardino, R. E. ISPOR GLOBAL GROUPS: USE OF MCDA IN HTA, COVERAGE AND REIMBURSEMENT DECISION-MAKING: EXPERIENCE AND INSIGHTS FROM EMEA, LATIN AMERICA AND ASIA-PACIFIC - ISPOR 22nd Annual European Congress, Copenhagen, Denmark, 2-6 November 2019
Kurnosova, T., Topór-Mądry, R., Kalo, Z., Holownia-Voloskova, M., ISPOR CENTRAL & EASTERN EUROPE CONSORTIUM: PROBLEMS AND SOLUTIONS FOR IMPLEMENTATION OF RISK SHARING SCHEMES IN THE COUNTRIES OF CENTRAL AND EASTERN EUROPE - ISPOR 22nd Annual European Congress, Copenhagen, Denmark, 2-6 November 2019
Augustine, T., Gill, J., Budde, K., Matas, A., Lan, J., Duerr, M., Hirji, I., Kalo, Z., Devercelli, G., Keown, P., INTERNATIONAL, MATCHED-COHORT CHECKERBOARD STUDY OF QUALITY OF LIFE AND DISEASE BURDEN IN KIDNEY TRANSPLANT (TX) PATIENTS WITH ANTIBODY-MEDIATED REJECTION (AMR)', Transplant International, Volume 32, pages 310-310, October 2019
Fasseeh, A.N, George, M., El Rabbat, M., Al Rabayah, A.A, Karam, R., Kristensen, F.B, Moneim, A.R.I.A., Jameleddine, M., Al-Saggabi, A. H., Alowayesh, M.S., Abaza, S., Chamova, J., Kalo, Z. PNS179 HTA IMPLEMENTATION IN MIDDLE EAST AND NORTH AFRICA: COMPARISON OF CURRENT AND PREFERRED STATUS,
Value in Health, Volume 22, Supplement 2, Pages S315-S316, May 2019
Harsanyi, A., Csanádi, M., Marky, K., Vincziczki, Á. Z., Kalo, Z., Inotai, A. PBI24 UTILIZATION AND SWITCHING PATTERNS OF BIOLOGICAL MEDICINES IN THE INDICATIONS OF INFLIXIMAB BEFORE AND AFTER PATIENT EXPIRY, Value in Health, Volume 22, Supplement 2, Page S51, May 2019
Almomani, E., Alabbadi, I., Fasseeh, A.N., Kaló, Z. PNS172 COMPARISON OF CURRENT AND PREFERRED STATUS OF HTA IMPLEMENTATION IN JORDAN,
Value in Health, Volume 22, Supplement 2, Page S314, May 2019
2018
Szilberhorn, L., Ágh, T., Kaló, Z. PRM131 - HEPATITIS C VIRUS ELIMINATION AND ERADICATION MODELS: A SYSTEMATIC LITERATURE REVIEW, Value in Health, Volume 21, Supplement 3, Page S378, 2018
Csanádi, M., Inotai, A., Németh, B., Oleshchuk, O., Lebega, O., Brodovskaya, A., Piniazhko, O., Kaló, Z. PHP300 - HEALTH TECHNOLOGY ASSESSMENT ROADMAP FOR UKRAINE - THE PERSPECTIVE OF STAKEHOLDERS ON CURRENT STATUS AND FUTURE OPPORTUNITIES, Value in Health, Volume 21, Supplement 3, Page S201, 2018
Rais, C., Kaló, Z., Csanádi, M., Negulescu, V. PHP292 - ROADMAP FOR IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT IN ROMANIA, Value in Health,
Volume 21, Supplement 3, Page S200, 2018
Potashman, M., Zelei, T., Bendes, R., Jakab, I., Szilberhorn, L., Elezbawy, B., Kaló, Z., Mann, M., Inuzuka, Y., Pitter, J. G. PND124 - HUMANISTIC AND ECONOMIC BURDEN OF PROGRESSIVE SUPRANUCLEAR PALSY: A SYSTEMATIC LITERATURE REVIEW, Value in Health, Volume 21, Supplement 3, Pages S349-S350, 2018
Inotai, A., Ágh, T., Karpenko, A. W., Zemplényi, A., Kaló, Z. PCN361 - HEALTH ECONOMIC VALUE PROPOSITIONS FOR SUBCUTANEOUS TRASTUZUMAB AND THEIR TRANSFERABILITY TO CENTRAL-EASTERN EUROPEAN COUNTRIES, Value in Health, Volume 21, Supplement 3, Page S75, 2018
Almasi, T., Fasseeh, A. N., Elezbawy, B., George, M., Abouelmaged, E., Arnaiz, F., Abaza, S. A., Nagy, B., Kaló, Z. PHP178 - ROLE OF SUPPLEMENTARY AND COMPLEMENTARY PRIVATE HEALTH INSURANCE IN SELECTED COUNTRIES, Value in Health, Volume 21, Supplement 3, Page S180, 2018
Kaló, Z., Inotai, A., Wijaya, K.E. PHP12 - Value-Based Decisions for Off-Patent Pharmaceuticals in Developing Countries – A Pilot Study Using Multi-Criteria Decision Analysis for Tenders in Indonesia, Value in Health, Volume 21, Supplement 2, Page S45, 2018
Maniadakis, N., Holtorf, A., Wijaya, K. E., Kaló, Z. PHP15 - Considerations for External Reference Pricing Practices in Developing Countries Learned from Experiences Across Europe and Other Developed Countries, Value in Health, Volume 21, Supplement 2, Page S45, September 2018
Harsányi, A., Csanádi, M., Márky, K., Németh, B., Vincziczki, Á.Z., Kaló, Z., Inotai, A. PHP52 - Biosimilar Infliximab Utilization After Patent Expiry: The Case of Colitis Ulcerosa and Rheumatoid Arthritis in Hungary, Value in Health, Volume 21, Supplement 1, Pages S95-S96, 2018
Nemeth, B., Zelei, T., Szeles, G., Jakab, I., Schmidt, F., Kalo, Z. PRM64 - Results of a Targeted Literature Review on the Cost-Effectiveness Models Developed for Retinopathy of Prematurity, Value in Health, Volume 21, Supplement 1, Page S221, 2018
Szilberhorn, L., Agh, T., Kalo, Z. Hepatitis C Virus Elimination and Eradication Models: A Systematic Literature Review. PRM131, ISPOR 21st Annual European Congress, poster, Barcelona, Spain, 10-14 November, 2018
Potashman, M., Zelei, T., Bendes, R., Jakab, I., Szilberhorn, L., Elezbawy, B., Kaló, Z., Mann, M., Inuzuka, Y., Pitter, J.G. Humanistic and Economic Burden of Progressive Supranuclear Palsy: A Systematic Literature Review. PND124, ISPOR 21st Annual European Congress, poster, Barcelona, Spain, 10-14 November 2018
Nemeth, B., Krupa, D., Staniak, A., Józwiak-Hagymásy, J., Vokó, Z. COMPARISON OF THE HEALTH TECHNOLOGY ASSESSMENT OFFICES OF HUNGARY AND POLAND BASED ON OBJECTIVE CRITERIA, ISPOR 21st Annual European Congress, poster, Barcelona, Spain, 10-14 November 2018
Nemeth, B., Bendes, R., Nagy, B., Deak, I.A., Toth, B., Koczian, K., Horvath, M., Croitoru, C., Tarhajova, M., Psota, M., Kuchar, J., Psenkova, M., Vokó, Z. COST-UTILITY ANALYSIS OF CARIPRAZINE COMPARED TO RISPERIDONE AMONG PATIENTS WITH NEGATIVE SYMPTOMS OF SCHIZOPHRENIA IN SELECTED CENTRAL AND EASTERN EUROPEAN COUNTRIES, ISPOR 21st Annual European Congress, poster, Barcelona, Spain, 10-14 November 2018
Nemeth, B., Bendes, R., Nagy, B., Corcoran, K., Lelli, F., Fonticoli, L., Vokó, Z. COST-UTILITY ANALYSIS OF CARIPRAZINE COMPARED TO RISPERIDONE AMONG PATIENTS WITH NEGATIVE SYMPTOMS OF SCHIZOPHRENIA IN SELECTED NORDIC COUNTRIES, ISPOR 21st Annual European Congress, poster, Barcelona, Spain, 10-14 November 2018
Csanádi, M., Inotai, A., Németh, B., Oleshchuk, O., Lebega, O., Brodovskaya, A., Piniazhko, O., Kaló, Z. HEALTH TECHNOLOGY ASSESSMENT ROADMAP FOR UKRAINE - THE PERSPECTIVE OF STAKEHOLDERS ON CURRENT STATUS AND FUTURE OPPORTUNITIES, ISPOR 21st Annual European Congress, poster, Barcelona, Spain, 10-14 November 2018
2017
Fasseeh, A.N., Nemeth, B., Molnar, A., Horvath, M., Koczian, K., Gotze, A., Kaló, Z. PMH18 - Indirect Costs and Caregiver Burden of Schizophrenia In European Countries – Results of A Systematic Literature Review, Value in Health, Volume 20, Issue 9, Page A712, 2017
Molnar, A., Nemeth, B, Inotai, A., Kaló, Z. PRM254 - Comparison of Weighting Methods Used During The Construction of Multiple-Criteria Decision Analysis Tool for Repeated Use In Lower Income Countries, Value in Health, Volume 20, Issue 9, Page A776, 2017
Szilberhorn, L., Ágh, T., Fasseeh, A.N., Kaló, Z. IN2 - Cost-Effectiveness and Modeling Approaches of Direct-Acting Antiviral Agents In Chronic Hepatitis C Infection: A Systematic Literature Review, Value in Health, Volume 20, Issue 9, Page A411, 2017
Kovacs, G., Almasi, T., Kaló, Z., Tuomi, M., Millier, A., Horvath, M., Koczian, K., Gotze, A., Zemplenyi, A. PMH21 - GDP And Population Size – Important Determinants of Schizophrenia-Related Healthcare Costs In The European Countries, Value in Health, Volume 20, Issue 9, Page A712, 2017
Molnar, A., Nagy, B., Kerpel-Fronius, A., Bajzik, G., Horvath, I., Moizs, M., Voko, Z. Modelling Patient Pathways Of Low-Dose Computed Tomography Screening For Lung Cancer In Hungary. Value in Health, Volume 20, Issue 9, Page A750, 2017
Szilberhorn, L., Agh, T., Fasseeh, A.N., Kalo, Z. Cost-Effectiveness and Modeling Approaches of Direct-Acting Antiviral Agents in Chronic Hepatitis C Infection: A Systematic Literature Review VALUE IN HEALTH 20:(9) p. A411. 1 p. ISPOR 20th Annual European Congress, presentation, Glasgow, Scotland, 4-8 November 2017
Zemplenyi, A., Csanadi, M., Pitter, J., Kalo, Z. Criteria identification and weight elicitation methods used in multiple criteria decision analysis (MCDA) of integrated care models. IME-META XI. Conference of the Hungarian Health Economics Association, oral presentation, Pécs, Hungary, 22-23 June 2017
Zemplenyi, A., Csanadi, M., Pitter, J., Kalo, Z., Voko, Z., Csikos, A. Economic evaluation of Palliative Care Consult Service in the framework of SELFIE Horizon 2020 project: study design. IME-META XI. Conference of the Hungarian Health Economics Association, poster presentation, Pécs, Hungary, 22-23 June 2017
Pitter, J., Csanadi, M., Nemeth, B. Proportion of patient co-payment fee in the cost of medicines reimbursed at a fixed amount: patterns in Hungary by age, sex, geography and socioeconomic status. IME-META XI. Conference of the Hungarian Health Economics Association, poster presentation, Pécs, Hungary, 22-23 June 2017
Pitter, J., Csanadi, M., Zemplenyi, A., Lukacs, G., Moizs, M., Kalo, Z., Voko, Z., Hodi, Zs., Svebis, M., Repa, I. The SELFIE empirical study of OnkoNetwork: study protocol and current patient enrolment status. IME-META XI. Conference of the Hungarian Health Economics Association, poster presentation, Pécs, Hungary, 22-23 June 2017
Kalo, Z. Health Economics 2017 - Quo Vadis? IME-META XI. Conference of the Hungarian Health Economics Association, oral presentation, Pécs, Hungary, 22-23 June 2017
Szilberhorn, L. Cost-effectiveness and modelling approach of direct antiviral agents treating hepatitis-C. IME-META XI. Conference of the Hungarian Health Economics Association, oral presentation, Pécs, Hungary, 22-23 June 2017
Inotai, A., Harsanyi, A., Csanadi, M., Kalo, Z. Rethinking the biosimilar drug policy. IME-META XI. Conference of the Hungarian Health Economics Association, oral presentation, Pécs, Hungary, 22-23 June 2017
Nemeth, B., Molnar, A. Comparison of weighting methods used during the construction of multicriteria decision analysis models IME-META XI. Conference of the Hungarian Health Economics Association, poster presentation, Pécs, Hungary, 22-23 June 2017
Csanadi, M., Kalo, Z. Current and preferred status of HTA implementation in Central and Eastern European countries. IME-META XI. Conference of the Hungarian Health Economics Association, oral presentation, Pécs, Hungary, 22-23 June 2017
Agh, T., Pitter, J.G., Nemeth, B., Voko, Z. PGI29 - Adherence to 5-Aminosalicylates and its Relation with Quality of Life and Health Care Resource Utilization in Patients With Inflammatory Bowel Disease: Evidence From US National Survey Data. ISPOR 22nd Annual International Meeting, Boston, MA, USA, May 2017
Nemeth, B., Molnar, A., Akehurst, R., Horvath, M., Koczian, K., Nemeth, G., Gotze, A., Voko, Z. PRM127 - Estimating Difference in Quality Adjusted Life Year Gain for Patients with Predominant Negative Symptoms of Schizophrenia Treated with Cariprazine and Risperidone. ISPOR 22nd Annual International Meeting, Boston, MA, USA, May 2017
Piniazhko, O., Nemeth B. PHP208 - Practical Issues of Determining Weights for Criteria to Be Used in an MCDA Framework - Based on a Case-Study. ISPOR 22nd Annual International Meeting, Boston, MA, USA, May 2017
Agh, T., Voko, Z., Heisel, O., Chiva-Razavi, S., Barbeau, M., Szilberhorn, L., Keown, P. Prevalence of Psoriatic Arthritis: Is Psoriatic Arthritis Underdiagnosed in Psoriasis Patients Seen in Dermatology Clinics? 16th Caribbean Dermatology Symposium, Aruba; January 17–21, 2017, 41st Hawaii Dermatology Seminar, Maui, HI, USA; January 29–February 3, 2017
Szilberhorn, L., Korosi, L., Vajer, P., Nagy, B., Voko, Z. Cost-effectiveness of controlling diabetes in primary care. The European Journal of Public Health 27:(Suppl. 3) p. 427. (2017)
2016
Nemeth, B., Kulchaitanaroaj, P., Lester-George, A., Huic, M., Pokhrel, S., Kalo, Z., Jozwiak-Hagymasy, J., Nagy, B. Identifying the Key Parameters of the European-study on Quantifying Utility of Investment in Protection From Tobacco (EQUIPT) Model, ISPOR 19th Annual European Congress, poster, Vienna, Austria, 29 October - 2 November 2016
Kaló, Z., Voko, Z., Clifton-Brown, E., Vasilescu, R.S., David, T., Gibson, E., Begum, N., Rao, N. Impact of National Criteria and Healthcare System Characteristics on Access to Biologic Dmards in Rheumatoid Arthritis in Europe, ISPOR 19th Annual European Congress, poster, Vienna, Austria, 29 October - 2 November, 2016
Nemeth, B., Piniazhko, O. MCDA Application in Central and Eastern Europe: Selection of the Most Important Criteria Based on Examples, ISPOR 19th Annual European Congress, poster, Vienna, Austria, 29 October - 2 November 2016
Csanadi, M., Prins, C., Grelinger, E., Fricke, F., Fuksa, L., Tesar, T., Manova, M., Lorenzovici, L., Kiss, A., Kalo, Z. Implication of External Price Referencing on Pharmaceutical List Prices in Europe, ISPOR 19th Annual European Congress, poster, Vienna, Austria, 29 October - 2 November 2016
Subtirelu, M., Mic, O.C., Daneasa, D., Csanadi, M., Atikeler, K., Dogan, E., Preda, A.L. What is the Level of Transparency in Health Technology Assessment Process in Hungary, Romania and Turkey? ISPOR 19th Annual European Congress, poster, Vienna, Austria, 29 October - 2 November, 2016
Inotai, A., Csanadi, M., Petrova, G., Bochenek, T., Tesar, T., York, K., Fuksa, L., Kostyuk, A., Araja, D., Lorenzovici, L., Egyed, K., Kalo, Z. Mapping of the Biosimilar Drug Policy in 10 Central Eastern European Countries, ISPOR 19th Annual European Congress, poster, Vienna, Austria, 29 October - 2 November 2016
Eder, B., Nagy, B. Budget impact analysis guideline: international and Hungarian perspective, ISPOR 19th Annual European Congress, poster, Vienna, Austria, 29 October - 2 November 2016
Inotai, A., Prins, C., Csanadi, M., Csetneki, K., Szegner, P., Vitezic, D., Kalo, Z. A Real Concern or Just a Hype? – Evidence on Negative Clinical Consequences of Switching From Originator to Biosimilar Based on a Systematic Literature Review, ISPOR 19th Annual European Congress, poster, Vienna, Austria, 29 October - 2 November, 2016
Agh, T. Comparative Analysis of Medication Possession Ratio Measures for Adherence to Single-Medication, ISPOR 19th Annual European Congress, poster, Vienna, Austria, 29 October - 2 November 2016
Bochenek, T., Godman, B.B., Bucsics, A., De Weerdt, E., Fürst, J., Gailite, E., Hotvedt, T.A., Huys, I., Inotai, A., Joppi, R., Malaj, A., Margus, K., Marković-Peković, V., Simoens, S., Slaby, J., Sović Brkičić, L., Gürpınar, E.U., Vella Bonanno, P., Warminska, E.J., Pilc, A. Systemic Solutions, Legislative and Organizational Frameworks Aimed to Prevent or Mitigate Drug Shortages in European Countries, ISPOR 19th Annual European Congress, poster, Vienna, Austria, 29 October - 2 November, 2016
Agh, T. The Value of Multi-Stakeholder Partnership in Advancing Patient Access in Central and Eastern Europe, ISPOR 19th Annual European Congress, oral presentation, Vienna, Austria, 29 October - 2 November 2016
Kalo, Z., Krasnova, L., Perikhanyan, A., Petrova, G., Pyadushkina, E. Burden of Hepatitis C in Central and Eastern European Countries, ISPOR 19th Annual European Congress, oral presentation, Vienna, Austria, 29 October - 2 November 2016
Kalo, Z., Knies, S., Mandrik, O., Severens, H. How to Transfer Economic Evidence to Low and Middle-Income Countries? Working Under Capacity Restrictions, ISPOR 19th Annual European Congress, oral presentation, Vienna, Austria, 29 October - 2 November 2016
Agh, T. Measuring Multiple Medication Adherence – Which Measure When?, ISPOR 19th Annual European Congress, oral presentation, Vienna, Austria, 29 October - 2 November 2016
Elek P, Harsányi A, Zelei T, Csetneki K, Kalo Z.Policy Objective of Generic Medicines from the Investment Perspective: The Case of Clopidogrel, ISPOR 19th Annual European Congress, oral presentation, Vienna, Austria, 29 October - 2 November 2016
Tesar, T., Hren, R., Inotai, A., Hlade Zore, D. Extending the Use of Biosimilar Drugs: Are We Willing to Accept the Uncertainty Related to Switching in Order to Improve Patient Access To Modern Medicines? ISPOR 19th Annual European Congress, oral presentation, Vienna, Austria, 29 October - 2 November 2016
Nemeth, B. ISPOR Hungary Chapter Meeting moderator, ISPOR 19th Annual European Congress, oral presentation, Vienna, Austria, 29 October - 2 November 2016
Hren, R., Kalo, Z., Kolasa, K. Risk-Sharing/Performance-Based Arrangements in Central & Eastern Europe: Implementation of Managed Entry Agreements, ISPOR 19th Annual European Congress, short course, Vienna, Austria, 29 October - 2 November 2016
Ansaripour, A., Franken, M., Uyl-de Groot, C., Kalo, Z., Redekop, W.K. PCN283 - Is External Reference Pricing A Threat to International Equal Affordability? VALUE IN HEALTH Volume 19, Supplement 7, Pages A759-A760. ISPOR 19th Annual European Congress. Vienna, Austria, 29 October - 2 November 2016
Brixner, D., Maniadakis, N., Kaló, Z., Hu, S., Johnston, A., Shen, J., Wijaya, K.E. PHP4 - Application of Multi-Criteria Decision Analysis (MCDA) Scoring as an HTA Methodology for off-Patent Pharmaceuticals (OPP) in Emerging Markets VALUE IN HEALTH Volume 19, Suppplement 7, Page. A815. 2016
Kalo, Z. How to Assess the Value of the Drug? An Overview on Producing Economic Evidence in the R&D Process. Oral presentation - CLINICAL THERAPEUTICS Volume 38, Issue 10S, Page e14. EACPT Focus Meeting, Opatija, Croatia, 6 October 2016
Kalo, Z., Vitezic, D. Implementation of Pharmacoeconomics to Support Pharmaceutical R&D Decisions (Workshop) CLINICAL THERAPEUTICS Volume 38, Issue 10S, page e19. EACPT Focus Meeting Opatija, Croatia, 6 October 2016
Kaló, Z. ISPOR RARE DISEASES SPECIAL INTEREST GROUP REPORT: CHALLENGES IN ASSESSING AND APPRAISING RARE DISEASE DIAGNOSTICS & TREATMENTS Pharmaca Volume 52, Supplement 1, page 18. 6th Adriatic Congress of Pharmacoeconomics and Outcomes Research. Bled, Slovenia, 2016
Nemeth, B., Csanadi, M., Kaló, Z. Strengths and weaknesses of HTA implementation in Hungary Pharmaca Volume 52, Supplement 1, page 20. 6th Adriatic Congress of Pharmacoeconomics and Outcomes Research. Bled, Slovenia, 2016
Ragab, S., Elsisi, G., Hassan, R., Aboushady, R., Atef, M., Kalo, Z., Abaza, S., Shaheen, M. CHALLENGES THAT FACE THE APPLICABILITY OF MULTI-INDICATION PRICING FOR INNOVATIVE PRODUCTS IN EGYPT VALUE IN HEALTH Volume 19, Supplement 3, Page A293. ISPOR 22nd Annual International Meeting, Washington DC, USA, 2016
George, M., Kalo, Z., Abbas, Y.M., Abaza, S. Driving UHC In Emerging Markets: an Egyptian Case VALUE IN HEALTH Volume 19, Supplement 3, Page A290. ISPOR 22nd Annual International Meeting, Washington DC, USA, 2016
Agh, T., Voko, Z., Heisel, O., Chiva-Razavi, S., Barbeau, M., Szilberhorn, L., Keown, P. Prevalence of psoriatic arthritis: is psoriatic arthritis underdiagnosed in psoriasis patients seen in dermatology clinics? [poster] 25th EADV Congress, Vienna, Austria, 28 September - 2 October 2016
Nemeth, B. Return on Investment - the Economics in Public Health. 4th International Congress on Health Economics and Outcomes Research. Belgrade, Serbia. 23-24 September 2016
Zsolyom, A., Szilberhorn, L., Nemeth, B., Nagy, B., Voko, Z. Impact of adjusting diabetes treatment pathways according to disease severity - The case of HbA1c and macular oedema. Economics Modelling and Diabetes: The Mount Hood 2016 Challenge, oral presentation, St Gallen, Switzerland, 16-18 September 2016
Kalo, Z. What can CEE and wider countries learn from EQUIPT: transferability of economic models at its best. 11th European Conference On Health Economics - EUHEA Conference, oral presentation, Hamburg, Germany, 13-16 July 2016
Zemplenyi, A., Pitter, J., Csanadi, M., Csetneki, K., Kaló, Z. Evaluating Integrated Care Models with Multiple Criteria Decision Analysis Methods. IME-META X. Conference of the Hungarian Health Economics Association, oral presentation, Budapest, Hungary, 15-16 June 2016
Eder, B., Nagy, B. Review of budget impact analysis methods, Hungarian and international review IME-META X. Conference of the Hungarian Health Economics Association, oral presentation, Budapest, Hungary, 15-16 June 2016
Joo, T., Voko, Z. The effects of tobacco control measures. Have smoking decreased in Hungary? X. Hungarian Health Economic Training and Conference, oral presentation, Budapest, Hungary, 15 - 16 June 2016
Almasi, T., Szilberhorn, L., Nagy, B. Multi-step screening strategies to recognize type 2 diabetes mellitus. IME-META X. Conference of the Hungarian Health Economics Association, oral presentation, Budapest, Hungary, 15-16 June 2016
Jakab, I., Nagy, B., Szeker, V., Kocsis, T., Nagyjanosi, L., Kalo, Z. Evidence-based reimbursement decisions on medical devices in Hungary. IME-META X. Conference of the Hungarian Health Economics Association, oral presentation, Budapest, Hungary, 15-16 June 2016
Pitter, J., Csanadi, M., Zemplenyi, A., Csetneki, K., Moizs, M., Kalo, Z., Repa, I. Identification of integrated care models for patients with multimorbidity in Hungary. IME-META X. Conference of the Hungarian Health Economics Association, oral presentation, Budapest, Hungary, 15-16 June 2016
Turi, G., Zsolyom, A., Voko, Z. The cost-effectiveness of oral cancer screening in Hungary. X. Hungarian Health Economic Training and Conference, Budapest, Hungary, 15 - 16 June 2016
Voko, Z., Zsolyom, A., Jermendy, Gy. Diabetes attributable mortality in Hungary. X. Hungarian Health Economic Training and Conference, oral presentation, Budapest, Hungary, 15 - 16 June 2016
Nemeth, B., Kulchaitanaroaj, P., Lester-George, A., Huic, M., Pokhrel, S., Kalo, Z. Identifying the Key Parameters of the European-Study on Quantifying Utility of Investment in Protection from Tobacco (EQUIPT) model. X. Hungarian Health Economic Training and Conference, Budapest, Hungary, 15 - 16 June 2016
Agh, T., Voko, Z., Heisel, O., Chiva-Razavi, S., Barbeau, M., Szilberhorn, L., Keown, P. Systematic literature review of the prevalence of psoriatic arthritis. Annual Congress, of Rheumatology, 2016, London, United Kingdom
Nemeth, B. Presentation of the EQUIPT Tobacco ROI Tool including policy proposals for selected Central and Eastern European countries & Presentation of post-workshop survey results. EQUIPT International Workshop, oral presentation, Zagreb, Croatia, 3 June 2016
Nemeth, B. Filling the gaps in HTA system - ISPOR views, The First CEE ISPOR Network Cross-boarder joint meeting, oral presentation, Bratislava, Slovakia, 6 May 2016
Freijer, K., Pitter, J., Volger, S. The DO’S and DON’TS of Performing A Scoping Review: Examples from the literature, ISPOR 21th Annual International Meeting, oral presentation, Washington DC, USA, 21-25 May, 2016
Bunz, T.J., Malmenas, M., Agh, T., Pednekar, P. A framework for measuring multiple medication adherence. ISPOR 21st Annual International Meeting, oral presentation, Washington DC, USA, 21-25 May 2016
Kvizhinadze, N., Piniazhko, O., Zah, V., Krasnova, L., Agh, T. Development and application of multi-criteria decision analysis in Central & Eastern Europe (CEE) in cooperation with western countries. ISPOR 21st Annual International Meeting, oral presentation, Washington DC, USA, 21-25 May 2016
Nemeth, B. Strengths and weaknesses of HTA implementation in Hungary. 7th ISPOR Adriatic Congress, oral presentation, Bled, Slovenia, 21 April 2016
Csanadi, M. Implementing a health technology assessment system in lower income EU member states. National Congress of Romanian Student Pharmacists, oral presentation, Craiova, Romania, 2 April 2016
Csanadi, M. Education in focus - Human capacity building in health policy and health economics. National Congress of Romanian Student Pharmacists, oral presentation, Craiova, Romania, 2 April 2016
2015
Kristensen, F.B., Kolasa, K., Huic, M., Kaló, Z. BUILDING LIGHT HTA APPROACH IN CENTRAL AND EASTERN EUROPEAN COUNTRIES BASED ON HTA RECOMMENDATIONS IN WESTERN EUROPEAN COUNTRIES: MORE HARM THAN GOOD? ISPOR 18th Annual European Congress, Milan, Italy, November 2015.
Lanitis, T., Kalo, Z., Muszbek, N. UNCERTAINTY OF UNCERTAINTY ESTIMATES IN ECONOMIC MODELLING OF ONCOLOGY. ISPOR 18th Annual European Congress, Milan, Italy, November 2015.
Zemplenyi, A., Kalo, Z., Boncz, I., Endrei, D., Mangel, L. A Microcosting Study of Radiation Therapy in Localized Prostate Cancer Patients in a Hungarian Tertiary Oncology Center. ISPOR 18th Annual European Congress, Value Health. Volume 18, Supplement 7, Page A354. Milan, Italy, November 2015
Ragab, S., Diaa, M., Hassan, R., Abou Shady, R., El-Sisi, G., Kalo, Z., Abaza, S., Shaheen, M., Abbas, Y. Pricing Policy for Pharmaceuticals in Egypt: Challenges and Opportunities. ISPOR 18th Annual European Congress, Value Health. Volume 18, Supplement 7, Page A523. Milan, Italy, November 2015
Kalo, Z., Csanadi, M., Vitezic, D., Huic, M., Husereau, D., Kristensen, F.B. Comparison of current and preferred status of HTA implementation in Central and Eastern European countries. ISPOR 18th Annual European Congress, Value Health. Volume 18, Issue 7, Page A538. Milan, Italy, November 2015
Csanadi, M., Fasseeh, A.N., Kalo, Z. Methodology of International Comparison of Pharmaceutical Prices. ISPOR 18th Annual European Congress, Value Health. Volume 18, Supplement 7, Page A539. Milan, Italy, November, 2015
Hegazy, A., George, M., Kalo, Z., Abaza, S., Abbas, Y.M., Atef, M. Challenges Along the Road to Universal Health Coverage in Egypt, an HIO Perspective. ISPOR 18th Annual European Congress, Value Health. Volume 18, Supplement 7, Pages A567-8. Milan, Italy, November 2015
Pitter, J.G., Vokó, Z., Halmos, Á., Józwiak, Á. Cost-utility analysis of potential campylobacter control measures in the food chain of indoor broiler chicken in the EU. ISPOR 18th Annual European Congress, Milan, Italy, November 2015
Nemeth, B. How Pharmacoeconomics Should Be Applied to Support Decisions in Lower Income European Countries? ISPOR 18th Annual European Congress, oral presentation, Milan, Italy, November 2015
Nemeth, B., Csordas, A., Papp, E. The cumulative analysis of checklist questionnaires filled out by the Hungarian HTA Office. ISPOR 18th Annual European Congress, Milan, Italy, November 2015
Nemeth, B., Eder, B. Assessing the cost-effectiveness of therapies in the third quadrant on the cost-effectiveness plane. ISPOR 18th Annual European Congress, Milan, Italy, November 2015
Kocsis, T., Papp, E., Nemeth, B., Juhasz, J. The cost of treatment of the new antiviral therapies against the Hepatitis C virus. ISPOR 18th Annual European Congress, Milan, Italy, November 2015
Agh, T., Bodnar, R., Olah, M., Meszaros, A. Adherence to inhaled antibiotics for the treatment of chronic pseudomonas aeruginosa infection in patients with cystic fibrosis: a systematic literature review. ISPOR 18th Annual European Congress, Milan, Italy, November 2015
Agh, T., Inotai, A., Szilberhorn, L., Culig, J., Petrova, G., Visnansky, M., Kalo, Z. A novel method for calculating medication adherence to poly-pharmacotherapy by linking general practice prescribing data and pharmacy dispensing records. ISPOR 18th Annual European Congress, Milan, Italy, November 2015
Agh, T., Pawaskar, M., Nagy, B., Szilberhorn, L., Voko, Z. Budget impact analysis of introducing lisdexamfetamine dimesylate for the treatment of binge eating disorder in the United States. ISPOR 18th Annual European Congress, Milan, Italy, November 2015.
Garrison, L.P., Kalo, Z. Making Sense of Risk-Sharing and Managed Entry Agreements, AMCP 2015 Nexus, Orlando, FL, USA 26-29 October 2015
Voko, Z., Pawaskar, M., Agh, T., Merész, G., Wadden, T., Herman, B.K. Characterization of health-related quality of life and healthcare utilization and cost in adults with binge eating disorder in a US population. 65th Annual Meeting of the Canadian Psychiatric Association, Vancouver, BC, Canada, 2015.
Inotai, A., Csanadi, M., Hanko, B., Kalo, Z. Principles Of Policy Framework In The Pharmaceutical Wholesale And Retail System In Lower Income European Countries. IX. Hungarian Health Economic Training and Conference, oral presentation, Budapest, Hungary, 24 - 25 June 2015
Meresz, G., Csetneki, K., Inotai, A., Kalo, Z. International Comparison Of Pharmaceutical Expenditures In Central-Eastern European Countries: Methodological Questions. IX. Hungarian Health Economic Training and Conference, oral presentation, Budapest, Hungary, 24 - 25 June 2015
Agh, T., Gaspar, K., Nagy, B., Kalo, Z. Value of a newborn child. IX. Hungarian Health Economic Training and Conference, oral presentation, Budapest, Hungary, 24 - 25 June 2015
Voko, Z. Question marks about the efficacy of breast cancer screening - a case study about the difficulties of evidence-based health policy. IX. Hungarian Health Economic Training and Conference, oral presentation, Budapest, Hungary, 24 - 25 June 2015
Pitter, G.J., Voko, Z., Halmos, A., Jozwiak, A. Cost-utility analysis of potential Campylobacter control measures in the food chain of indoor broiler chicken in the EU. IX. Hungarian Health Economic Training and Conference, Budapest, Hungary, 24 - 25 June 2015
Zsolyom, A., Nagy, B., Nagyjanosi, L., Dessewffy, Z., Steiner, T., Kalo, Z., Voko, Z. Cost-effectiveness of introducing a risk-stratified screening questionnaire (FINDRISC) for type 2 diabetes. IX. Hungarian Health Economic Training and Conference, oral presentation, Budapest, Hungary, 24 - 25 June 2015
Inotai, A., Csanadi, M., Hanko, B., Kalo, Z. Principles of policy framework in the pharmaceutical wholesale and retail system in lower income European countries. Value in Health. Volume 18, Supplement 3, Page A74. ISPOR XX. Annual congress, Philadelphia, PA, USA, 16-20 May 2015
Agh, T., Pawaskar, M., Voko, Z., Nagy, B., Lachaine, J. The cost-effectiveness of lisdexamfetamine dimesylate for the treatment of binge eating disorder. ISPOR XX. Annual International Congress Philadelphia, PA, USA, 16 - 20 May 2015
Pitter, G.J., Voko, Z., Halmos, A., Jozwiak, A. Need for Reliable Disease Burden Estimates to Support Food Safety Decision Making: the example of Human Campylobacteriosis in the European Union. IAFP's European Symposium on Food Safety - oral presentation. Cardiff, Wales 20-22 April 2015
2014
Kalo, Z., Alabbadi, I., Al Ahdab, O. G., Al-Badriyeh, D., Alowayesh, M., Al-Saggabi, A. H., Elmahdawy, M., Tanzi, V. L., Ali, F. M. H., Alsultan, H. S., Elsisi, G. H., Akhras, K. S., Voko, Z., Kanavos, P. PHP25 IMPLICATIONS OF EXTERNAL PRICE REFERENCING OF PHARMACEUTICALS IN MIDDLE EASTERN COUNTRIES. ISPOR 17th Annual European Congress Amsterdam, The Netherlands, November 2014
Inotai, A., Abonyi-Toth, Z., Rokszin, G., Voko, Z. PRM57 Occurrence, survival and annual cost of colorectal-, breast-, prostate- and lung cancer in Hungary. ISPOR 17th Annual European Congress Amsterdam, The Netherlands, November 2014
Kalo, Z., Vamossy, I., Harsanyi, A.. Investment aspects of generic drug policies in countries with severe resource constraints. ISPOR 17th Annual European Congress Amsterdam, The Netherlands, November 2014
Zsolyom, A., Nagy, B., Nagyjanosi, L., Dessewffy, Z., Steiner, T., Kalo, Z., Voko, Z. PDB148 Cost-effectiveness of the introduction of an organized adherence program for type 2 diabetes in Hungary. ISPOR 17th Annual European Congress Amsterdam, The Netherlands, November 2014
Lorenzovici, L., Szekely, A., Agh, T., Vamossy, I., Kelemen, L., Finta, H., Kalo, Z. PIH33 Economic evaluation of ulipristal acteate for the treatment of patients with moderate and severe symptoms of uterine fibroids in Romania. ISPOR 17th Annual European Congress Amsterdam, The Netherlands, November 2014
Meresz, G.: Coauthor networks: beyond citations. Budapest Business Intelligence Forum, 26th November 2014.
Meresz, G..: Analysing scientometric data to relevate publication activity and coauthor networks. Hungarian Natural Language Processing Meetup, 26 September 2014
Meresz, G., Foldesi, Cs., Nagyistok, Sz., Vincziczk,i A. Z. The publication activity of the Hungarian Health Economics Association. IME-META VIII. National Health Economic Training and Conference, poster and presentation, Budapest, Hungary, 18 - 19 June 2014
Meresz, G., Gyurcsan, G. Cs., Salfer, B. Easy Come, Hardly Go: Epidemiological Methods to Evaluate the Effect of Ispor Board of Directors Membership on Publication Activity. Value in Health, Volume 17, Issue 7, page A555. 2014.
Gregory, V., Barbeau, M., Machnicki, G., Voko, Z., Heisel, O., Keown, P. Real world research in Latin America: opportunities, sources and barriers. ISPOR 19th Annual International Congress Montreal, Canada, May 2014
Agh, T., Pawaskar, M., Kovacs, G., Kalo, Z., Supina, D., Voko, Z. The Humanistic and economic burden of bulimia nervosa and binge eating disorder: a systematic review. ISPOR 19th Annual International Congress Montreal, Canada, May 2014
Inotai, A., Kalo, Z., Vitezic, D., Petrova, G. PHP137 Transferability Of International Evidence On The Benefits Of Innovative Medicines Into Central Eastern European Countries. ISPOR 19th Annual International Congress Montreal, Canada, May 2014
Gaspar, K., Kalo, Z., Agh, T., Vamossy, I., Lehmann, M., Nagy, B. PRM23 The long-term economic value of a new-born child comparison of the human capital and the lifetime investment approaches. ISPOR 19th Annual International Meeting, Montreal, Canada, May 2014
Zsolyom, A., Nagy, B., Dessewffy, Z., Steiner, T., Kalo, Z., Voko, Z. PDB123 Cost-effectiveness of the introduction of a risk-stratified population screening for type 2 diabetes in Hungary. ISPOR 19th Annual International Meeting, Montreal, Canada, May 2014
2013
Agh, T., Meszaros, A. Association of medication adherence and quality of life in patients with COPD. ESPACOMP 17th Annual Meeting Budapest, Hungary, November 2013
Zsolyom, A., Meresz, G., Nagyjanosi, L., Nagyistok, Sz., Nagy, B., Kalo, Z., Voko, Z. PRM87 External validation of the Syreon Diabetes Model. ISPOR 16th Annual European Congress Dublin, Ireland, November 2013
Agh, T., Inotai, A., Bartfai, Z., Meszaros, A. PRS47 Relationship between medication adherence and quality of life in COPD – systematic review. ISPOR 16th Annual European Congress Dublin, Ireland, November 2013
Abonyi-Toth, Zs., Kalo, Z., Agh, T., Inotai, A., Katona, L., Rokszin, Gy., Jozwiak-Hagymasy, J. PCV148 Assessment of generic drug policy implementation by measuring persistence with antihypertensive drug therapies after patent expiry. ISPOR 16th Annual European Congress Dublin, Ireland, November 2013
Kalo, Z., Abonyi-Toth, Zs., Rokszin, Gy., Katona, L., Agh, T., Inotai, A. PCV147 Impact of multiple switching on health care costs and outcomes in generic drug policies. ISPOR 16th Annual European Congress Dublin, Ireland, November 2013
Vamossy, I., Agh, T., Blasszauer, C., Bago, M., Meszaros, A., Kalo, Z. PIH53 Societal burden of hysterectomy in reproductive-aged women with uterine fibroids. ISPOR 16th Annual European Congress Dublin, Ireland, November 2013
Nagyistok, Sz., Szilberhorn, L., Nagy, B., Kalo, Z. Cost-benefit analysis of KMOP tender - Opportunity or curse? VII. Hungarian Health Economic Training and Conference, poster, Budapest, Hungary, 19 - 20 June 2013
Nagyistok, Sz., Borsi, A., Sinkovits, B. Multivariate data analysis of META sessions. VII. Hungarian Health Economic Training and Conference, poster, Budapest, Hungary, 19 - 20 June, 2013
Zsolyom, A., Csicsari, K. Nurse scheduling of the Pulmonary Institute in Eger. VII. Hungarian Health Economic Training and Conference, poster, Budapest, Hungary, 19 - 20 June 2013
Meresz, G., Kobori, L., Mocsari, D., Kosoczki, E., Hirka, G., Monostory, K., Kalo, Z. Personalized medicine in kidney transplantation: health economic analysis of the CYPtestTM diagnostic method. VII. Hungarian Health Economic Training and Conference, presentation, Budapest, Hungary, 19 - 20 June 2013
Boehler, C., Kalo, Z. A new spectre is haunting Europe! External price referencing and its impact on lower-income European economies, VII. Hungarian Health Economic Training and Conference, presentation, Budapest, Hungary, 19 - 20 June 2013
Soroncz-Szabo, T., Helter, T., Nagy, B., Kalo, Z., Bischof, M., Hodgkins, P., Erder, M.H., Setyawan, J. Attention deficit/hyperactivity disorder: Are all the costs, benefits and outcomes being captured in economic evaluations? Attention Deficit Hyperactive Disorder Volume 5, Issue 2, Page 246. June 2013
Boehler, C., Meresz, G., Kalo, Z. PHP65 Pharmaceutical spending levels across Europe – Consequences of current international pricing policies on lower-income countries. ISPOR 18th Annual International Meeting. Poster, New Orleans, USA, 18-22 May 2013
Boehler, C. A new spectre is haunting Europe! International price referencing and its impact on lower-income European economies, III. Croatian and III. Adriatic Congress on Pharmacoeconomics and Outcomes Research, "The Role of Pharmacoeconomics in Developing Countries", Brijuni, Croatia, 25-27 April 2013
Helter, T. Moving beyond QALYs - measuring and valuing outcomes of alcohol misuse interventions, III. Croatian and III. Adriatic Congress on Pharmacoeconomics and Outcomes Research, "The Role of Pharmacoeconomics in Developing Countries", Brijuni, Croatia, 25-27 April 2013
Kalo, Z. Contribution of clinical trials to the economy in Central-Eastern Europe - the case of Hungary, III. Adriatic Congress on Pharmacoeconomics and Outcomes Research, "The Role of Pharmacoeconomics in Developing Countries", Brijuni, Croatia, 25-27 April 2013
2012
Agh, T., Inotai, A., Meszaros, A. PIH33 Utility and human capital loss in asthma, chronic obstructive pulmonary disease and rheumatoid arthritis - The impact of prevalence, disease-specific mortality and utility decrement on overall health burden. ISPOR 15th Annual European Congress Berlin, Germany, November 2012
Meresz, G., Nagyjanosi, L., Nagy, B., Dessewffy, Z., Voko, Z., Kalo, Z. PRM85 Internal validation of the Syreon diabetes model ISPOR 15th Annual European Congress Berlin, Germany, November 2012
Nagy, B., Jozwiak-Hagymasy, J., Timar, Gy., Kovacs, G., Meresz, G., Vamossy, I., Agh, T., Voko, Z., Kalo, Z. PIH24 Economic evaluation of ulipristal acetate tablets for the treatment of patients with moderate and severe symptoms of uterine fibroids ISPOR 15th Annual European Congress Berlin, Germany, November 2012
Zemplenyi, A., Endrei, D., Boncz, I., Kalo Z. PHP96 Evidence-Based Structural Reform in the Provision of Hospital Care: The Case Study of Merging Two Institutions in Hungary. ISPOR 15th Annual European Congress Berlin, Germany, November 2012
Penzes, M., Kalo, Z., Pozsgay, C., Kalotai, Z. PHP31 The Value of Investigational Medical Products. ISPOR 15th Annual European Congress Berlin, Germany, November 2012
Ward, S., Nagy, B., Gray, L. Cost-effectiveness analysis of three year versus one year imatinib for the treatment of patients at high risk of disease recurrence following surgical resection of KIT (CD117) positive gastrointestinal stromal tumours (GIST). European Society of Medical Oncology 2012, Vienna, Austria, 29 September 2012
Jozwiak-Hagymasy, J., Meresz, G., Marton, I., Nagyjanosi, L., Nagyistok, Sz., Dessewffy, Z., Nagy, B., Voko, Z., Kalo, Z.: Quantifying costs and utilities for the health economic model to compare the prevention, treatment and management strategies of type 2 diabetes. VI. Hungarian Health Economic Training and Conference, Budapest, Hungary, 21 June 2012
Agh, T., Inotai, A., Meszaros, A. Health burden of asthma, COPD and rheumatoid arthritis in Hungary. VI. Hungarian Health Economic Training and Conference 2012. Budapest, Hungary, 21 June 2012
Kalo, Z., Inotai, A., Meresz, G. PHP44 International Comparison of Pharmaceutical Expenditure in Middle-Income Countries: Methodological Questions ISPOR 17th Annual International Meeting Washington, D.C., USA, June 2012
Meszaros, A., Agh, T., Bartfai, Z., Orosz, M. Quality of life decrement and health burden in asthma and COPD. 57th Congress of Hungarian Respiratory Society, Budapest, Hungary, 14 -16 June 2012.
Kalo, Z. Capability Building in Health Economics. Oral presentation at the Pricing & Reimbursement Future Trends Workshop for Egypt, Sharm El-Sheik, Egypt, May 2012
Kalo, Z. Patient access to pharmaceuticals in Eastern Europe: Differential pricing for Low and Middle-Income countries. Oral presentation at the Pricing & Reimbursement Future Trends Workshop for Egypt, Sharm El-Sheik, Egypt, May 2012
Meszaros, A., Agh, T. Adherence and quality of life in patients with COPD. 18th Congress of Hospital Pharmacists, Szeged, Hungary, 17-19 May 2012.
Kalo, Z., Vitezić, D. Applied pharmacoeconomics: How pharmacoeconomics can be applied to support decisions by different stakeholders in health care? First Bosnian-Hezegovinian and Second Adriatic Congress on Pharmacoeconomics and Outcomes Research, Folia medica Facultatis Medicinae Universitatis Saraeviensis 2012; Volume 47, Supplement.1, Pages 10-11. Sarajevo, Bosnia and Herzegovina, 24-26 April 2012
Kalo, Z. Managed Entry Agreements - Patient Access Schemes. Oral Presentation at the 1st Middle East Africa Pricing & Reimbursement Future Trends Workshop, Muscat, Oman, 2012
Kalo, Z. HTA Capability Building. Oral Presentation at the 1st Middle East Africa Pricing & Reimbursement Future Trends Workshop, Muscat, Oman, 2012
Kalo, Z. Pricing and reimbursement of pharmaceuticals in Central-Eastern European countries. Oral presentation at the Symposium on the “Pricing and Reimbursement of Medicines – European Practices” under the patronage of the Parliamentary Committee to the 41st National Assemble, Sofia, Bulgaria, 2012
Kalo, Z. Heading of Pharmacoeconomics and Possibilities of the Cross-Border Cooperation - View of ISPOR. Oral presentation at the Conference on the Optimalisation of Methods of Pharmacoeconomics and Health Technology Assessment: Importance for National Health Policy and Cross-Border Cooperation, Bratislava, WHO Office Slovakia, 2012.
Kalo, Z. Optimalisation of Methods of Pharmacoeconomics And Health Technology Assessment Methods in Hungary. Oral presentation at the Conference on the Optimalisation of Methods of Pharmacoeconomics and Health Technology Assessment: Importance for National Health Policy and Cross-Border Cooperation, Bratislava, WHO Office Slovakia, 2012.
Kalo, Z. Development of Pharmacoeconomics and Potential of its Application as a Modern Tool of the Medicine Policy in the World and in Europe. Oral presentation at the Conference on the Optimalisation of Methods of Pharmacoeconomics and Health Technology Assessment: Importance for National Health Policy and Cross-Border Cooperation, Bratislava, WHO Office Slovakia, 2012.
2011
Agh, T., Inotai, A., Meszaros, A. PRS62 Comparison of generic and disease-specific quality of life measures in chronic obstructive pulmonary disease. ISPOR 14th Annual European Congress, Madrid, Spain, November 2011
Kalo, Z. Can we alleviate current market failures from international price referencing of pharmaceuticals in middle-income countries? View of an academic expert from a middle-income country, Issue Panel oral presentation at ISPOR 14th Annual European Congress, Madrid, Spain, 2011
Kalo, Z., Boncz, I. Implications of economic crisis on health care decision-making in Hungary, Regional Forum oral presentation ISPOR 14th Annual European Congress, Madrid, Spain, November 2011
Nagy, B., Nagyjanosi, L., Nagyistok, Sz., Jozwiak-Hagymasy, J., Dessewffy, Z., Meresz, G., Kalo, Z., Voko, Z. PDB82 Development of a Health Economic Model to Compare the Prevention, Treatment and Management Strategies of Type 2 Diabetes. ISPOR 14th Annual European Congress Madrid, Spain, November 2011
Nagyjanosi, L., Martos, E., Bodonyi, D., Voko, Z. PCV67 A health-economic analysis of salt intake reduction in Hungary ISPOR 14th Annual European Congress Madrid, Spain, November 2011
Nemeth, J., Nagyjanosi, L., Nagyistok, S., Tolnayne Csattos, M., Szabone Berta, I., Kincses E., Szulyak, E., Boer, I., Hundzsa, G., Kalo, Z., Berta, A. PSS17 Societal Burden of Blindness in Hungary ISPOR 14th Annual European Congress Madrid, Spain, November 2011
Skoupa, J., Orlewska, E., Kalo, Z., Hajek, P. PCN121 Challenges in Conducting Pharmacoeconomic Analyses in Central and Eastern Europe – Case Study on Breast Cancer ISPOR 14th Annual European Congress Madrid, Spain, November 2011
Inotai, A., Meresz, G., Kalo, Z. PHP73 Government Reduces Public Pharmaceutical Expenditure in Hungary: Rational Decisions in Challenging Economic times?. ISPOR 14th Annual European Congress Madrid, Spain, November 2011
Inotai, A., Meresz, G., Jozwiak-Hagymasi, J., Kalo, Z. Burden of disease model of disease-related malnutrition in Europe. V. Hungarian Health Economic Training and Conference, presentation, Budapest, Hungary, 29 - 30 June 2011
Nagy, B., Nagyjanosi, L., Nagyistok, Sz., Jozwiak-Hagymasy, J., Dessewffy, Z., Kalo, Z., Voko, Z. Development of a health economic model to compare the prevention, treatment and management strategies of type 2 diabetes. V. Hungarian Health Economic Training and Conference, Budapest, Hungary, 29 - 30 June 2011
Meresz, G., Inotai, A., Kalo, Z. Assessment of the pharmaceutical expenditure in Hungary, V. Hungarian Health Economic Training and Conference, presentation, Budapest, Hungary, 29 - 30 June 2011
Kalo, Z., Landa, K., Dolezal, T., Voko, Z. PCN116 Transferability of Nice recommendations for pharmaceutical therapies in oncology to Central-Eastern European Countries ISPOR 16th Annual International Meeting Baltimore (MD) USA, May 2011
Kalo, Z., Voko, Z. Health technology assessment: a European collaboration. Expert Review of Pharmacoeconomics and Outcomes Research. Volume 11, Issue 1, pages 41 - 43, February 2011
Kalo, Z.: Feasibility of HTA implementation in Central-Eastern European countries. Oral presentation at the The Value of Innovation – HTA in Dialogue with the experts, AmCham / LAWG meeting, Bucharest, Romania, 2011
Kalo, Z.: Current Structure and Future of Pricing and Reimbursement in European Middle-Income countries. Oral presentation at the SECOND INTERNATIONAL SEMINAR ON HEALTH ECONOMICS AND HEALTH TECHNOLOGY ASSESSMENT: How does HTA support Value for Money? Bandung, Indonesia, 2011
Kalo, Z.: Principles for a good HTA. Oral presentation at the SECOND INTERNATIONAL SEMINAR ON HEALTH ECONOMICS AND HEALTH TECHNOLOGY ASSESSMENT: How does HTA support Value for Money? Bandung, Indonesia, 2011
Szepesi G, Kalo Z, Antal J, Szepezdi Zs, Nagyjanosi L: Economic impact of clinical trials on the GDP, Oral presentation at the 10th European Association for Clinical Pharmacology and Therapeutics (EACPT) Congress, Budapest, Hungary, 2011
2010
Botlik, O., Kalotai, Z., Dessewffy, Z., Kalo, Z. PHP34 Patient access to innovative medicines in Hungary ISPOR 13th Annual European Congress Prague, Czech Republic, November 2010
Kalo, Z., Nagyjanosi, L. PUK14 Healthcare cost of renal replacement therapy in Hungary. ISPOR 13th Annual European Congress, Praga, Czech Republic, November 2010
Kalo, Z., Nagyjanosi, L., Kovacs, G., Nagyistok, Sz. PHP122 Competitiveness of Hungary in international clinical trials ISPOR 13th Annual European Congress Prague, Czech Republic, November 2010
Meszaros, A., Agh, T. PRS36 Adherence to medication and health-related quality of life in patients with COPD: SGRQ - an alternative method to identify non-adherence. ISPOR 13th Annual European Congress Prague, Czech Republic, November 2010
Kalo, Z., Nemeth, A., Jozwiak-Hagymasy, J. PMH48 Impact of once-daily dosing on drug discontinuation of patients with schizophrenia ISPOR 13th Annual European Congress Prague, Czech Republic, November 2010
Nagy, B., Nagy, J., Alegre, P. PMH32 Economic evaluation of agomelatine in major depressive disorders in Hungary. ISPOR 13th Annual European Congress Prague, Czech Republic, November 2010
Nagyjanosi, L., Kalo, Z. PHP13 Implementation of the transparency directive in Hungary, ISPOR 13th Annual European Congress. Praga, Czech Republic, November 2010
Voko, Z., Nagyjanosi, L., Kalo, Z. PCN103 Cost-effectiveness analysis of adding HPV vaccination to cervical cancer screening program in Hungary. ISPOR 13th Annual European Congress, Praga, Czech Republic, November 2010
Voko, Z., Nagyjanosi, L., Kalo, Z. PDB24 Direct health care costs of diabetes mellitus in Hungary, ISPOR 13th Annual European Congress, Prague, Czech Republic, November 2010
Agh, T., Meszaros, A. Medication adherence in patients treated for COPD. European Society for Patient Adherence, Compliance and Persistence (ESPACOMP). Lodz, Poland, 17-18 September 2010
Nagy, B., Rakonczai, P. Risk sharing methods applied with capitation payment in Hungary: a trade-off between selection and efficiency. IV.Hungarian Health Economic Training and Conference, 30 June 2010
Voko, Z., Nagyjanosi, L., Kalo, Z., Margitai, B., Koos, T., Kovi, R. Economic evaluation of cervical cancer screening strategies. IV. Hungarian Health Economic Training and Conference, Budapest, Hungary 30 June 2010
Orosz, M., Galffy, G., Agh, T., Kovacs, D., Meszaros, A. The everyday life of patients with asthma or COPD. 56th Congress of Hungarian Respiratory Society, Sopron, Hungary, 2-5 May 2010
Agh, T., Bartfai, Z., Meszaros, A. Relation of adherence to quality of life in COPD patients. 56th Congress of Hungarian Respiratory Society, Sopron, Hungary, 2-5 May 2010
Voko, Z., Nagyjanosi, L., Kalo, Z., Margitai, B., Koos, T., Kovi, R. Economic evaluation of cervical cancer screening strategies. 8th European Conference on Health Economics. Helsinki, Finnland, 2010
Herczeg, B., Hoschek, P. M., Molnar, M. Z., Kalo, Z. Clinical and Socio-Demographic Determinants of Utility Among Patients With Renal Transplantation: 2796. Transplantation, 90, 107. XXIII International Congress of The Transplantation Society, Vancouver, British Columbia, Canada, 2010
Kalo, Z., Marton. J., Mihaly, S., Gerendy, P., Kiss, Z. Cost-Benefit Analysis of Extended Donor Coordinator System To Increase Organ Donation Rates in Hungary: 2741. Transplantation, 90, 250. XXIII International Congress of The Transplantation Society, Vancouver, British Columbia, Canada, 2010
Kalo, Z. Comparison the Economic Value of Different Types of Organs in Renal Transplantation: 1866. Transplantation, 90, 251. XXIII International Congress of The Transplantation Society, Vancouver, British Columbia, Canada, 2010
Kalo, Z., Kiss, Z., Gerendy, P., Nagyjanosi, L., Voko, Z. Cost of Renal Replacement Therapy in Hungary: 2749. Transplantation, 90, 735. XXIII International Congress of The Transplantation Society, Vancouver, British Columbia, Canada, 2010
Kalo, Z. Role of HTA and transparent decision-making criteria to improve the access of patients to medical devices, Oral presentation at the EUCOMED MedTech Forum, Brussels, Belgium, 2010
Kalo, Z. Cost-effectiveness and reimbursement of lung cancer treatment expenses in the region. Oral presentation at the 12th Central-European Lung Cancer Conference, Budapest, Hungary, 2010
Kalo, Z. Access of patients to innovative oncology therapies in European countries, Oral presentation at the 8th Congress of The Balkan Union of Oncology, Sibiu, Romania, 2010
2009
Kalo, Z. Strategic pricing of pharmaceuticals in the European Union. Oral presentation at the 4th International Symposium on Evidence-Based Health Care, HTA & Pricing, Central and Eastern European Society of Technology Assessment in Health Care (CEESTAHC), Krakow, Poland, 7 - 8 December 2009
Karamustafalioglu, O., Ozdemir, O., Kalo, Z. PMH43 The Cost-Effectiveness of Quetiapine XR in the Prevention of Relapse and Hospitalization in Schizophrenia ISPOR 12th Annual European Congress Paris, France, October 2009
Kalo, Z., Pekli, M., Inotai, A., Remak, E. PHP10 Quality assurance of fourth hurdle in Hungary – a methodological approach. ISPOR 12th Annual European Congress, Paris, France, October 2009
Nagy, B., Brennan, A., Skultety, L., Nagy, J., Szentesi, A., Dessewffy, Z.., Kalotai, Z. The cost-effectiveness of rivastigmine transdermal patch in the management of patients with mild and moderate Alzheimer’s disease. III. Hungarian Health Economic Training and Conference, Budapest, Hungary, 8 July 2009
Nagy, J., Nagy, B., Lovas, K., Tolna, J., Skultety, L. Disease Burden in Depression. IME-META III. Hungarian Health Economic Training and Conference, Budapest, Hungary, 8 July 2009
Timar, Gy., Nagyjanosi, L., Kalo, Z. Aclasta IME-META III.Hungarian Health Economic Training and Conference, Budapest, Hungary, 8 July 2009
2008
Kalo, Z., Lukovics, M., Verebes, E.D., Sampar, P. PHP32 Cost-Benefit Analysis of Public Hospital Development ISPOR 11th Annual European Congress Athens, Greece, November 2008
Inotai, A., Meszaros, A. PMS41 Cost-effectiveness of celecoxib compared to conventional NSAIDs and NSAID+PPI combination therapy in the treatment of rheumatoid arthritis. ISPOR 11th Annual European Congress, Athens, Greece, November 2008
Nagy, B., Brennan, A., Brandtmüller, A., Thomas, S.K., Gallagher, M., Sullivan, S.D., Akehurst, R. Introducing a methodology to use ADL outcomes in the assessment of the cost-effectiveness of AD treatments: a case study using rivastigmine patch. International Conference on Alzheimer's Disease, Chicago, IL, USA, 26 - 31 July 2008
Nagy, B., Sipos, J., Dozsa, Cs., Borcsek, B. Implementing risk-adjusted capitation payments with health care reforms: the case of Hungary. 7th European Conference on Health Economics, Roma, Italy, 24 July 2008
Nagy, B., Rakonczai, P. Predicting health care expenditures with demographic characteristics for designing capitation payments in Hungary. II. Hungarian Health Economic Training and Conference, Budapest, Hungary, 9 June 2008
Bacskai, M., Komaromi, T., Nagy, B., Kalo, Z. PHP17 How mandatory price reduction of reimbursed pharmaceuticals could result in increased pharmaceutical expenditure? ISPOR 13th Annual International Meeting Toronto, Ontario, Canada, May 2008
Nagy, B., Brennan, A., Brandtmuller, A., Thomas, S.K., Sullivan, S.D., Akehurst, R. The cost-utility of the rivastigmine transdermal patch in the management of patients with moderate Alzheimer’s disease in the US. American Association for Geriatric Psychiatry Annual Meeting, Orlando, Florida, USA, 14 - 17 March 2008
Nagy, B. What sort of capitation do people need? The efficient and equitable allocation of resources. Nepszabadsag Conference, 11 March 2008.
Kalo, Z. Concepts of Pharmacoeconomics. Oral presentation at the Oncology Practice Summit Meeting, Beirut, Lebanon, 2008
Kalo, Z. Value-based decision-making for drug formulary inclusions. Oral presentation at the Oncology Practice Summit Meeting, Beirut, Lebanon, 2008
